Jacobs Levy Equity Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $137K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $28.5K | Sell |
|
|||||
|
2024
Q1 | $274K | Sell |
|
|||||
|
2023
Q4 | $361K | Sell |
|
|||||
|
2023
Q3 | $356K | Sell |
|
|||||
|
2023
Q2 | $536K | Sell |
|
|||||
|
2023
Q1 | $501K | Sell |
|
|||||
|
2022
Q4 | $381K | Sell |
|
|||||
|
2022
Q3 | $673K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $305K | Buy |
|
|||||
|
2020
Q3 | $198K | Sell |
|
|||||
|
2020
Q2 | $213K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $160K | Buy |
|
|||||
|
2016
Q4 | $166K | Buy |
|